Thymalfasin - Shenzen Neptunus Interlong Bio-Technique CompanyAlternative Names: Recombinant human thymosin-α-1 for injection - Shenzen Neptunus Interlong Bio-Technique Company
Latest Information Update: 08 Jan 2016
At a glance
- Originator Shenzhen Neptunus Interlong Bio-Technique
- Class Adjuvants; Antineoplastics; Antivirals; Oligopeptides; Thymus hormones
- Mechanism of Action Th1 cell stimulants; Th2-cell-inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Phase II Cancer